A citation-based method for searching scientific literature

Anita Y Kinney, Laurie E Steffen, Barbara H Brumbach, Wendy Kohlmann, Ruofei Du, Ji-Hyun Lee, Amanda Gammon, Karin Butler, Saundra S Buys, Antoinette M Stroup, Rebecca A Campo, Kristina G Flores, Jeanne S Mandelblatt, Marc D Schwartz. J Clin Oncol 2016
Times Cited: 57







List of co-cited articles
340 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
811
7

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
654
7

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
67
7

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
77
7

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
49
8

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
49
8

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
155
7

Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.
Yaojen Chang, Aimee M Near, Karin M Butler, Amanda Hoeffken, Sandra L Edwards, Antoinette M Stroup, Wendy Kohlmann, Amanda Gammon, Saundra S Buys, Marc D Schwartz,[...]. J Oncol Pract 2016
9
44

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
342
7

Analysis of Advantages, Limitations, and Barriers of Genetic Counseling Service Delivery Models.
Stephanie A Cohen, Rachelle C Huziak, Shanna Gustafson, Robin E Grubs. J Genet Couns 2016
26
15

Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
A R Bradbury, L Patrick-Miller, D Fetzer, B Egleston, S A Cummings, A Forman, L Bealin, C Peterson, M Corbman, J O'Connell,[...]. Clin Genet 2011
29
13

Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings.
Eileen McDonald, Amanda Lamb, Barbara Grillo, Lee Lucas, Susan Miesfeldt. J Genet Couns 2014
27
14

Real world experience with cancer genetic counseling via telephone.
Rebecca Sutphen, Barbara Davila, Heather Shappell, Tricia Holtje, Susan Vadaparampil, Sue Friedman, Michele Toscano, Joanne Armstrong. Fam Cancer 2010
28
14

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
Catharine Wang, Richard Gonzalez, Kara J Milliron, Victor J Strecher, Sofia D Merajver. Am J Med Genet A 2005
53
7


Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
Beth N Peshkin, Tiffani A Demarco, Kristi D Graves, Karen Brown, Rachel H Nusbaum, Diana Moglia, Andrea Forman, Heiddis Valdimarsdottir, Marc D Schwartz. Genet Test 2008
42
9

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
150
7

Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.
Neal J Meropol, Mary B Daly, Hetal S Vig, Frank J Manion, Sharon L Manne, Carla Mazar, Camara Murphy, Nicholas Solarino, Vadim Zubarev. J Telemed Telecare 2011
33
12

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
283
7

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Jill Baran, Marvin Schwalb. Cancer Control 2004
27
14

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
120
7


Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.
Tiffani A DeMarco, Beth N Peshkin, Bryn D Mars, Kenneth P Tercyak. J Genet Couns 2004
61
7

A Systematic Review of Randomized Controlled Trials to Assess Outcomes of Genetic Counseling.
Barbara A Athens, Samantha L Caldwell, Kendall L Umstead, Philip D Connors, Ethan Brenna, Barbara B Biesecker. J Genet Couns 2017
33
12


Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
233
7

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.
Kurt D Christensen, Wendy R Uhlmann, J Scott Roberts, Erin Linnenbringer, Peter J Whitehouse, Charmaine D M Royal, Thomas O Obisesan, L Adrienne Cupples, Melissa B Butson, Grace-Ann Fasaye,[...]. Genet Med 2018
21
19

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
525
7

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
690
7

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
31
12

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Sari Lieberman, Ariela Tomer, Avi Ben-Chetrit, Oded Olsha, Shalom Strano, Rachel Beeri, Sivan Koka, Hila Fridman, Karen Djemal, Itzhak Glick,[...]. Genet Med 2017
25
16

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
40
10

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
185
7

Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services.
Nan M Solomons, Amanda E Lamb, Frances L Lucas, Eileen F McDonald, Susan Miesfeldt. Telemed J E Health 2018
17
23

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
Brittany A L Batte, Amanda S Bruegl, Molly S Daniels, Kari L Ring, Katherine M Dempsey, Bojana Djordjevic, Rajyalakshmi Luthra, Bryan M Fellman, Karen H Lu, Russell R Broaddus. Gynecol Oncol 2014
56
5

Predictors of genetic testing decisions: a systematic review and critique of the literature.
Kate Sweeny, Arezou Ghane, Angela M Legg, Ho Phi Huynh, Sara E Andrews. J Genet Couns 2014
32
9

Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.
Aurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, Gérald Fioretta, Hyma Schubert, Christine Bouchardy, Pierre O Chappuis, Simone Benhamou. Breast Cancer Res Treat 2014
14
21

Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?
Chanita Hughes Halbert, Lisa Kessler, Aliya Collier, Benita Weathers, Jill Stopfer, Susan Domchek, Jasmine A McDonald. J Genet Couns 2012
27
11


Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
20
15

Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas.
M Trottier, J Lunn, R Butler, D Curling, T Turnquest, R Royer, M R Akbari, T Donenberg, J Hurley, S A Narod. Clin Genet 2015
11
27

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
108
5

What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
Inez Adams, Juleen Christopher, Karen Patricia Williams, Vanessa B Sheppard. J Cancer Educ 2015
23
13

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
5

Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling.
Patrick R Benusiglio, Marina Di Maria, Leila Dorling, Anne Jouinot, Antoine Poli, Sophie Villebasse, Marine Le Mentec, Béatrice Claret, Diane Boinon, Olivier Caron. Fam Cancer 2017
10
30

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
177
5

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
5

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
5

Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
L Baumanis, J P Evans, N Callanan, L R Susswein. J Genet Couns 2009
51
5

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
142
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.